• Share
  • Email
  • Print

Cindy Hong

Fax +86.21.3251.8918

Ms. Hong is a partner in the firm’s Shanghai office. She concentrates her practice area in anti-corruption compliance and corporate transactions. She has experience advising multi-national companies in connection with their China operations, whether at the outset of their investment or in connection with the compliant functioning of their ongoing businesses. She advises companies in a wide range of industries including advertising, telecommunications, e-commerce, transportation and logistics, manufacturing, and nonprofit organizations.

In the anti-corruption area, Ms. Hong represents companies across the spectrum of potential compliance risk. At the outset of investment, she conducts anti-corruption due diligence in mergers & acquisitions. Leveraging her knowledge in various business operations, Ms. Hong assists clients in assessment of risks to design an effective compliance program addressing the risks unique to clients’ business. Ms. Hong is fluent in English, Cantonese and Mandarin and has been working in China for almost a decade, her clients benefit from her language proficiency and deep local insights to roll out their Asia Compliance program. In connection with clients’ ongoing operations, Ms. Hong regularly assists her clients to conduct internal investigation including matters involving the Foreign Corrupt Practices Act, the UK Bribery Act and PRC anti-corruption laws. She also conducts investigations into alleged misconduct involving employees, third parties, including agents and business partners, as well as advising on enforcement actions.

Speaking Engagements

  • “Anti-Corruption Compliance in China: Minimizing FCPA and Chinese Anti-Bribery Law Violations,” Strafford Webinar, January 25, 2017
  • “Internal Investigations: Start to Finish,” 5th Compliance Summit North Asia Hong Kong, November 17, 2016
  • “Managing Legal Risks and Developing an Effective Compliance Program,” Lexis-Nexis Roundtable, April 14, 2016
  • “Employee Misconduct Investigation” & “The Trends & Roles of Digital Evidence Technology in Investigations,” Innoxcell Annual Symposium Hong Kong, April 13, 2016
  • “China Healthcare Compliance,” Seton Hall Asia-Pacific Healthcare Compliance Certification Program, March 3, 2016
  • “Conducting Internal Investigations in Asia-Pacific,” 4th Annual Compliance Summit Asia, November 10, 2015
  • “Enforcement of the U.S. Foreign Corrupt Practices Act and Other Anti-Bribery Legislation: Impact of High Profiles Investigation on Business Dealings in Asia,” TRACE Certification Anti-Bribery Workshop, September 9, 2015
  • “The Long Arm of U.S. Laws and How They Impact Your Compliance Procedures: Case Studies on the Volcker Rule and FCPA,” 2015 In-House Congress Seoul, September 2, 2015
  • Acted for a publicly traded advertising company in its various acquisitions of Chinese advertising companies in China.
  • Acted for a multi-national company in its various acquisitions of Chinese internet companies in the online job search space.
  • Acted for a company traded on the Thailand Stock Exchange in its acquisition of manufacturing plant and business in China.
  • Acted for various multi-national companies in their joint ventures in China.
  • Acted for a leading US company in its supply and licensing arrangements in China.
  • Advising multi-national companies in its internal investigation with UK Bribery Act, FCPA and PRC commercial briery implications and conducting anti-corruption focused interviews. 
  • Advising US-based companies and their non-US affiliates on antibribery, corporate governance and FCPA compliance, investigations and training.
  • Conducting an internal investigation for the Bangkok subsidiary of an international corporation on potential exposure to breaches of anti-competitive conduct laws by its employees.
  • Advising multi-national companies in its compliance audit of its operations in China